GPT and cancer: In rare cases, however, cells are able to bypass senescence either by reactivating telomerase or by a telomerase-independent recombination-based mechanism employed by 10–15% of cancers known as alternative lengthening of telomeres (ALT) (reviewed in [7,8]).